Press Releases

Washington, DC - Americans for Safe Access (ASA) and CannaKeys are partnering together to help broaden access to cannabis research and demystify the science of cannabis to support improved patient outcomes. As part of this partnership, all ASA members will receive a 30% discount on the CannaKeys 360 platform. In addition, ASA and CannaKeys will be working together on educational activities to help accelerate the use and safe adoption of cannabinoid therapeutics.

Washington DC -- Today, Americans for Safe Access (ASA) submitted comments to the Office of National Drug Control Policy (ONDCP) in response to the White House’s request for comments issued on July 7. The focus of the request for public input was on the impact of federal drug control policy on equity communities. ASA’s comment letter addressed the challenges faced by patients using medical cannabis ranging from access, patient rights and civil protections to affordability, safety and consistency of cannabis medicine. The letter also raises the need for ONDCP leadership in reorganizing the agendas of federal departments and agencies to facilitate a pathway to federally-sanctioned cannabis medicine, and reform federal drug policies that have disproportionately harmed equity communities.

Today, Americans for Safe Access (ASA), the largest national member-based organization of patients, medical professionals, scientists, and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research and Cannabis Patient Care™, a leading multimedia platform dedicated to advancing medical research, education, and treatment in the cannabis industry are excited to announce a partnership to share educational content and patient stories.

As part of their agreement, ASA will by-line articles focused on patient and advocate experiences in upcoming issues of Cannabis Patient Care™. In addition, Cannabis Patient Care™ will conduct interviews with various ASA chapters and highlight the work going on across the US to improve patient access and legalization efforts. All ASA members will receive a complimentary subscription to Cannabis Patient Care™.

Today, Senate Majority Leader Chuck Schumer, along with colleagues Cory Booker (NJ) and Ron Wyden (OR), introduced a discussion draft of the Cannabis Administration and Opportunity Act. The long-awaited introduction of this discussion draft invites input from other members of Congress, stakeholder organizations like ASA, and the public to weigh in on the bill’s contents and work to improve the measure before the final draft of the bill is introduced after September 1, 2021.

WASHINGTON, DC — On April 28 and 29 of this year, Americans for Safe Access (ASA) will hold its 9th annual National Medical Cannabis Unity conference. For the last 8 years, ASA has brought together medical cannabis patients, caregivers, veterans, advocates, medical professionals, industry business leaders, health care providers, researchers, legal and regulatory experts, industry representatives to talk about the most important issues regarding medical cannabis access for patients. 

ASA’s Product Safety Certification Program, PFC, Internationally Recognized

Washington, DC —  American’s for Safe Access has achieved accreditation to the ISO/IEC 17065:2012 (Certificate #5284.01) standard for certifying bodies through their PFC Program. PFC is the first and only compliance program to obtain this international accreditation in the cannabis and hemp industries. This accreditation signifies that American for Safe Access’ PFC product safety program operates in a competent, consistent and impartial manner, giving clients and consumers the confidence and trust that is established by an impartial third party.

Washington, DC --  Americans for Safe Access (ASA) is mobilizing advocates as part of it’s Biden-Harris Can Do It: No Patient Left Behind campaign to contact Secretary Denis McDonough of the U.S. Department of Veterans Affairs to allow VA physicians to recommend medical cannabis to veteran patients. 

Washington, DC -- Today, Americans for Safe Access (ASA) launched its Biden-Harris Can Do It: No Patient Left Behind campaign to seize the first 100 days of the new Biden- Harris administration as an opportunity to influence medical cannabis policies and mobilize a movement to pass comprehensive federal legislation in the 117th Congress.

Washington, DC -- Last night, the U.S. Senate passed unanimously by voice vote the Cannabidiol and Marihuana Research Expansion Act (S. 2032). This marks the first time that a cannabis reform bill has passed the Senate. 

This bill combines two bills: the Cannabidiol Research Expansion Act and the Marijuana Effective Drug Studies Act. If enacted into law, the bill would remove existing barriers to scientific and medical research on cannabis and its compounds including CBD (cannabidiol). Click here for the full list of provisions.